NDC 68462-581 – Fenofibrate
Fenofibrate 134 mg/1 · Capsule · Oral
Product NDC68462-581
Product details
- Brand name
- Fenofibrate
- Generic name
- Fenofibrate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA205566
- Marketed since
- April 7, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Peroxisome Proliferator Receptor alpha Agonist
Active ingredients
- Fenofibrate 134 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68462-581-01 | 100 CAPSULE in 1 BOTTLE (68462-581-01) | Apr 7, 2017 |
Recalls mentioning this NDC
- D-0314-2025 Apr 16, 2025 · Class II
CGMP Deviations
Other Fenofibrate products
- 50090-7994 Fenofibrate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6120 Fenofibrate 134 mg/1 · Capsule · A-S Medication Solutions
- 27241-118 Fenofibrate 67 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-120 Fenofibrate 200 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-119 Fenofibrate 134 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 62332-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60687-713 Fenofibrate 200 mg/1 · Capsule · American Health Packaging